Rare diseases
Investigational molecules
Locations
Study on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis
AustriaStudy of secukinumab and prednisone combination therapy for patients with giant cell arteritis (GCA): Evaluation of treatment effectiveness and safety
AustriaStudy on Palbociclib and Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer
AustriaStudy on Acalabrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients Without del(17p) or TP53 Mutation
AustriaStudy on the Safety and Effectiveness of TAK-755 (Apadamtase Alfa) for Patients with Severe Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
AustriaStudy on MaaT013 for Treating Acute Gastrointestinal Graft-Versus-Host Disease in Patients Not Responding to Ruxolitinib
AustriaStudy on the Effects and Safety of Prasinezumab for Patients with Early Parkinson's Disease
AustriaStudy on Enzalutamide and Leuprorelin Acetate for Men with High-Risk Nonmetastatic Prostate Cancer After Treatment
AustriaStudy on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis
AustriaStudy of Atezolizumab and Tiragolumab for Patients with Unresectable Esophageal Squamous Cell Carcinoma After Chemoradiotherapy
AustriaStudy of Acalabrutinib and Tafasitamab for Patients with Previously Treated Marginal Zone Lymphoma
AustriaStudy on Long-Term Safety and Effectiveness of Liposomal Ciclosporin A for Patients with Bronchiolitis Obliterans Syndrome After Lung Transplantation
AustriaTell us about your condition – we search every trial in Europe and connect you with the right site.
